Exactly why and how GLP-1 medications lower breast cancer risk is not fully understood, but experts have theories
Policymakers continue evaluating broader access to obesity treatments, while pharmaceutical manufacturers develop new indications and next-generation therapies
It's a marketing umbrella for multi-strain probiotic supplements positioned for people using GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Zepbound, Mounjaro)
Novo is confident in its ability to retain users in India
If you notice emotional dips or obsessive thoughts, speak up early
and device patents for the delivery mechanisms. According to the Initiative for Medicines, Access, and Knowledge, a nonprofit group that monitors drug patents, Novo Nordisk has filed at least 49 semaglutide patents